Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Antyhypertensive therapy-based secondary prevention of ischemic stroke

Full Text:


The paper reviews the data available in the literature on the prevention of ischemic stroke by using antihypertensive therapy. It gives international guidelines and the results of randomized placebo-controlled trials of the use of different antihypertensive drugs in patients with prior stroke or transient ischemic attack. The possible neuroprotective effects of angiotensin II receptor blockers are discussed when analyzing the advantages of eprosartan over nitrendipine in the secondary prevention of stroke. The realities and optimization of secondary prevention of stroke in outpatient practice are analyzed.

About the Authors

Vladimir Anatolyevich Parfenov

Department of Nervous Diseases, Faculty of Therapeutics

S V Verbitskaya

Department of Nervous Diseases, Faculty of Therapeutics

Yu A Starchina

Department of Nervous Diseases, Faculty of Therapeutics


1. <div><p>Шевченко О.П., Праскурничий Е.А., Яхно Н.Н. и др. Артериальная гипертония и церебральный инсульт. М., 2001;192 с.</p><p>Суслина З.А., Гераскина Л.А., Фонякин А.В. Артериальная гипертония, сосудистая патология мозга и антигипертензивное лечение. М.: Медиаграфикс, 2006;200 с.</p><p>Sacco R.L., Adams R., Albers G. et al. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Stroke 2006;37:577—617.</p><p>European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack. Cerebrovasc Dis 2008;25:457—507.</p><p>Суслина З.А., Фонякин А.В., Гераскина Л.А. и др. Практическая кардионеврология. М.: ИМА-ПРЕСС, 2010;304 с.</p><p>Furie K.L., Kasner S.E., Adams R.J. et al. Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2011;42:227—76.</p><p>Prospective Studies Collaboration. Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts. Lancet 1995;346:1647—53.</p><p>Lewington S., Clarke R., Qizilbash N. et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903—13.</p><p>Vasan R.S., Beiser A, Seshardi S. et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Stud. JAMA 2002;287:1003—10.</p><p>Chalmers J., MacMahon S., Anderson C. et al. Clinician's manual on blood pressure and stroke prevention. Second ed. London, 2000;129 p.</p><p>Rashid P., Leonardi-Bee J., Bath P.P. Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular Events. Stroke 2003;34:2741—8.</p><p>Zhang H., Thijs L., Staessen J.A. Blood Pressure Lowering for Primary and Secondary Prevention of Stroke. Hypertension 2006;48:187—95.</p><p>Lawes C.M.M., Bennett D.A., Feigin V.L. et al. Blood pressure and stroke: an overview of published reviews. Stroke 2004;35:776—85.</p><p>Lakhan S.E., Sapko M.T. Blood pressure lowering treatment for preventing stroke recurrence: a systematic review and meta-analysis. Int Arch Med 2009;2:30.</p><p>Rothwell P.M., Howard S.C., Spence J.D. et al. Relationship between Blood Pressure and Stroke Risk in Patients With Symptomatic Carotid Occlusive Disease. Stroke 2003;34:2583—92.</p><p>The Dutch TIA Trial Study Group. Trial of secondary prevention with atenolol after transient ischemic attack or nondisabling ischemic stroke. Stroke 1993;24:543—8.</p><p>Post-stroke antihypertensive treatment study. A preliminary result. PATS Collaborating Group. Chin Med J 1995;108:710—7.</p><p>Yusuf S., Sleight P., Pogue J. et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145—53.</p><p>Svensson P., de Faire U., Sleight P. et al. Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE Substudy. Hypertension 2001;38:e28-e32.</p><p>PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient schaemic attack. Lancet 2001;358:1033—41.</p><p>Schrader J., Luders S., Kulschewski A. et al. Mortality and morbidity after stroke, Eprosartan compared with Nitrendipine for secondary prevention. Principal results of a prospective randomised controlled study (MOSES). Stroke 2005;36:1218—26.</p><p>Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events. N Engl J Med 2008;359:1225-37.</p><p>De la Sierra A. Effects of eprosartan on target organ protection. Vasc Health Risk Manag 2006;2:79-85.</p><p>Schrader J., Kulschewski A., Dendorfer A. Inhibition of the renin-angiotensin system and the prevention of stroke. Am J Cardiovasc Drugs 2007;7:25-37.</p><p>Парфенов В.А., Старчина Ю.А., Яхно Н.Н. Эпросартан (теветен) в профилактике повторного инсульта и когнитивных нарушений. Неврол журн 2007;1:46—51.</p><p>Schwander B., Gradl B., Zöllner Y. et al. Cost-utility analysis of eprosartan compared to enalapril in primary prevention and nitrendipine in secondary prevention in Europe — the HEALTH model. Value Health 2009;12:857-71.</p><p>Парфенов В.А., Рыжак А.А. Неврологические аспекты оптимизации антигипертензивной терапии. Неврол журн 2003;2:26—9.</p><p>Вербицкая С.В., Парфенов В.А. Вторичная профилактика инсульта в амбулаторных условиях. Неврол журн 2011;1:17—21.</p></div><br />

For citation:

Parfenov V.A., Verbitskaya S.V., Starchina Yu.A. Antyhypertensive therapy-based secondary prevention of ischemic stroke. Neurology, Neuropsychiatry, Psychosomatics. 2012;4(1):96-101. (In Russ.)

Views: 484

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)